Results 111 to 120 of about 2,375,747 (287)
MiR‐513a promotes human erythroid differentiation by modulating c‐Jun
FEBS Open Bio, EarlyView.During early human erythropoiesis, miR‐513a promoted erythroid differentiation in primary human CD34+ hematopoietic stem‐progenitor cells and human TF‐1 erythroleukemic cells by indirectly decreasing c‐Jun and phospho‐c‐Jun expression, which are associated with increased GATA1 expression.MinJung Kim, Brittany Taylor, Shannon Bolten, Christian L. Eberly, Mahliya Abdurahman, T. Michael Creed, Acong Yang, Taylor L. Hatchet, Tristan Dyson, Shuo Gu, Curt I. Civin, Tami J. Kingsbury +11 morewiley +1 more sourceThe Aging Blood: Cellular Origins, Circulating Drivers, and Therapeutic Potential
Aging and Cancer, EarlyView.As a conduit linking all organs, the blood system both reflects and actively drives systemic aging. This review highlights how circulating pro‐aging and antiaging factors and age‐associated hematopoietic stem cell dysfunction contribute to immunosenescence and multi‐organ decline, positioning the hematopoietic system as a target for aging intervention. Hanqing He, Jianwei Wangwiley +1 more sourceVisual Recovery Reflects Cortical MeCP2 Sensitivity in Rett Syndrome
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective
Rett syndrome (RTT) is a devastating neurodevelopmental disorder with developmental regression affecting motor, sensory, and cognitive functions. Sensory disruptions contribute to the complex behavioral and cognitive difficulties and represent an important target for therapeutic interventions.Alex Joseph Simon, Nathalie Picard, Valeria d'Andrea, Enchi Chang, Joseph Leffler, Eleonora Centofante, Matthew Taylor, Francesca Bardi, Francesca Cavicchiolo, Takao K. Hensch, Stefano Panzeri, Chinfei Chen, Michela Fagiolini +12 morewiley +1 more sourceMeasurement of the gamma gamma* --> eta and gamma gamma* --> eta' transition form factors
, 2011 Comment: 21 pages, 18 postscript figures, published ...Sanchez P. del Amo, Lees J. P., Poireau V., Prencipe E., Tisserand V., Garra Tico J., Grauges E., Martinelli M., Milanes D. A., Palano A., Pappagallo M., Eigen G., Stugu B., Sun L., Brown D. N., Kerth L. T., Kolomensky Y.u. G., Lynch G., Osipenkov I. L., Koch H., Schroeder T., Asgeirsson D. J., Hearty C., Mattison T. S., McKenna J. A., Khan A., Blinov V. E., Botov A. A., Buzykaev A. R., Druzhinin V. P., Golubev V. B., Kravchenko E. A., Onuchin A. P., Serednyakov S. I., Skovpen Y.u. I., Solodov E. P., Todyshev K. Y.u., Yushkov A. N., Bondioli M., Curry S., Kirkby D., Lankford A. J., Mandelkern M., Martin E. C., Stoker D. P., Atmacan H., Gary J. W., Liu F., Long O., Vitug G. M., Campagnari C., Hong T. M., Kovalskyi D., Richman J. D., West C. A., Eisner A. M., Heusch C. A., Kroseberg J., Lockman W. S., Martinez A. J., Schalk T., Schumm B. A., Seiden A., Winstrom L. O., Cheng C. H., Doll D. A., Echenard B., Hitlin D. G., Ongmongkolkul P., Porter F. C., Rakitin A. Y., Andreassen R., Dubrovin M. S., Meadows B. T., Sokoloff M. D., Bloom P. C., Ford W. T., Gaz A., Nagel M., Nauenberg U., Smith J. G., Wagner S. R., Ayad R., Toki W. H., Jasper H., Petzold A., Spaan B., Kobel M. J., Schubert K. R., Schwierz R., Bernard D., Verderi M., Clark P. J., Playfer S., Watson J. E., Andreotti M., Bettoni D., Bozzi C., Calabrese R., Cecchi A., Cibinetto G., Fioravanti E., Franchini P., Garzia I., Luppi E., Munerato M., Negrini M., Petrella A., Piemontese L., Baldini Ferroli R., Calcaterra A., de Sangro R., Finocchiaro G., Nicolaci M., Pacetti S., Patteri P., Peruzzi I. M., Piccolo M., Rama M., Zallo A., Contri R., Guido E., Lo Vetere M., Monge M. R., Passaggio S., Patrignani C., Robutti E., Bhuyan B., Prasad V., Lee C. L., Morii M., Edwards A. J., Adametz A., Marks J., Uwer U., Bernlochner F. U., Ebert M., Lacker H. M., Lueck T., Volk A., Dauncey P. D., Tibbetts M., Behera P. K., Mallik U., Chen C., Cochran J., Crawley H. B., Meyer W. T., Prell S., Rosenberg E. I., Rubin A. E., Gritsan A. V., Guo Z. J., Arnaud N., Davier M., Derkach D., da Costa J. Firmino, Grosdidier G., Le Diberder F., Lutz A. M., Malaescu B., Perez A., Roudeau P., Schune M. H., Serrano J., Sordini V., Stocchi A., Wang L., Wormser G., Lange D. J., Wright D. M., Bingham I., Chavez C. A., Coleman J. P., Fry J. R., Gabathuler E., Hutchcroft D. E., Payne D. J., Touramanis C., Bevan A. J., Di Lodovico F., Sacco R., Sigamani M., Cowan G., Paramesvaran S., Wren A. C., Brown D. N., Davis C. L., Denig A. G., Fritsch M., Gradl W., Hafner A., Alwyn K. E., Bailey D., Barlow R. J., Jackson G., Lafferty G. D., Anderson J., Cenci R., Jawahery A., Dallapiccola C., Sciacca C., Raven G., Corwin L. A., Strube J., Bomben M., CALDERINI, GIOVANNI, Marchiori G., Ocariz J., ANGELINI, CARLO, BATIGNANI, GIOVANNI, BETTARINI, STEFANO, Casarosa G., FORTI, FRANCESCO, GIORGI, MARCELLO, PAOLONI, EUGENIO, RIZZO, GIULIANA, Adye T., de Monchenault G. Hamel, Vasseur G., Benitez J. F., Lewis P., Su D., Bellis M., Lanceri L., Albert J., Banerjee S.w., Kowalewski R., Roney J. M., Latham T. E., Dasu S., Wu S. L. +231 moreopenaire +8 more sourcesNetwork Localization of Fatigue in Multiple Sclerosis
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background
Fatigue is among the most common symptoms and one of the main factors determining the quality of life in multiple sclerosis (MS). However, the neurobiological mechanisms underlying fatigue are not fully understood. Here we studied lesion locations and their connections in individuals with MS, aiming to identify brain networks ...Olli Likitalo, Jaakko Kungshamn, Albert Bellmunt‐Gil, Silvia Tommasin, Abhineet Ojha, Matias Viitala, Juho Aaltonen, Jyrki Lötjönen, Juha Koikkalainen, Pauli Ylikotila, Patrizia Pantano, Merja Soilu‐Hänninen, Juho Joutsa +12 morewiley +1 more sourceTHE REACTION E+E--] GAMMA-GAMMA(GAMMA) AT Z0 ENERGIES
, 1991 The total and differential cross-sections for the reaction e+e- –> gamma-gamma(gamma) are measured at centre of mass energies around 91 GeV using an integrated luminosity of 4.7 pb-1. The agreement with the QED prediction is good. Consequently there is no evidence for non-standard channels which would have the same experimental signature.ABREU, P, ADAM, W, ADAMI, F, ADYE, T, AKESSON, T, ALEKSEEV, GD, ALLEN, P, ALMEHED, S, ALTED, F, ALVSVAAG, SJ, AMALDI, U, ANASSONTZIS, E, ANTILOGUS, P, APEL, WD, APSIMON, RJ, ASMAN, B, ASTIER, P, AUGUSTIN, JE, AUGUSTINUS, A, BAILLON, P, BAMBADE, P, BARAO, F, BARBIELLINI, G, BARDIN, DY, BARONCELLI, A, BARRING, O, BARTL, W, BATTAGLIA, M, BATES, MJ, BAUBILLIER, M, BECKS, KH, BEESTON, CJ, BEGALLI, M, BEILLIERE, P, BELOKOPYTOV, Y, BELTRAN, P, BENEDIC, D, BENLLOCH, JM, BERGGREN, M, BERTRAND, D, BIAGI, S, BIANCHI, F, BIBBY, JH, BILENKY, MS, BILLOIR, P, BJARNE, J, BLOCH, D, BLYTH, S, BOGOLUBOV, PN, BOLOGNESE, T, BONAPART, M, BONESINI, M, BONIVENTO, W, BOOTH, PSL, BORATAV, M, BORGEAUD, P, BORISOV, G, BORNER, H, BOSIO, C, BOTNER, O, BOUQUET, B, BOZZO, M, BRAIBANT, S, BRANCHINI, P, BRAND, KD, BRENNER, RA, BRICMAN, C, BROWN, RCA, BRUMMER, N, BRUNET, JM, BUGGE, L, BURAN, T, BURMEISTER, H, BUYTAERT, JAMA, CACCIA, M, CALVI, M, ROZAS, AJC, CAMPAGNE, JE, CAMPION, A, CAMPORESI, T, CANALE, V, CAO, F, CARROLL, L, CASO, C, CASTELLI, E, GIMENEZ, MVC, CATTAI, A, CAVALLO, FR, CERRITO, L, CHARPENTIER, P, CHECCHIA, P, CHELKOV, GA, CHEVALIER, L, CHLIAPNIKOV, P, CHOROWICZ, V, CIRIO, R, CLARA, MP, COLLINS, P, CONTRERAS, JL, CONTRI, R, COSME, G, COUCHOT, F, CRAWLEY, HB, CRENNELL, D, CROSETTI, G, CROSLAND, N, CROZON, M, MAESTRO, JC, CZELLAR, S, DAGORET, S, DAHLJENSEN, E, DALMAGNE, B, DAM, M, DAMGAARD, G, DARBO, G, DAUBIE, E, DAUNCEY, PD, DAVENPORT, M, DAVID, P, DEANGELIS, A, DEBEER, M, DEBOECK, H, DEBOER, W, DECLERCQ, C, LASO, MDMD, DEGROOT, N, DELAVAISSIERE, C, DELOTTO, B, DEMIN, A, DEFOIX, C, DELIKARIS, D, DELORME, S, DELPIERRE, P, DEMARIA, N, DERKAOUI, J, DICIACCIO, L, DIJKSTRA, H, DJAMA, F, DOLBEAU, J, DONSZELMANN, M, DOROBA, K, DRACOS, M, DREES, J, DRIS, M, DUFOUR, Y, DULINSKI, W, DZHELYADIN, R, EEK, LO, EEROLA, PAM, EKELOF, T, EKSPONG, G, PEISERT, AE, ENGEL, JP, FASSOULIOTIS, D, FENYUK, A, ALONSO, MF, FERRER, A, FILIPPAS, TA, FIRESTONE, A, FOETH, H, FOKITIS, E, FOLEGATI, P, FONTANELLI, F, FORSBACH, H, FRANEK, B, FRENKIEL, P, FRIES, DC, FRODESEN, AG, FRUHWIRTH, R, FULDAQUENZER, F, FURNIVAL, K, FURSTENAU, H, FUSTER, J, GAGO, JM, GALEAZZI, G, GAMBA, D, GARCIA, C, GARCIA, J, GASPARINI, U, GAVILLET, P, GAZIS, EN, GERBER, JP, GIACOMELLI, P, GLITZA, KW, GOKIELI, R, GOLOVATYUK, VM, CADENAS, JJGY, GOOBAR, A, GOPAL, G, GORSKI, M, GRACCO, V +199 moreopenaire +3 more sourcesOlink Proteomics Analysis Reveals Heterogeneous Responses to FcRn Blockade in Anti‐AChR Antibody‐Positive Myasthenia Gravis: FGF‐19 as a Novel Biomarker
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective
This study aimed to systematically observe the clinical manifestations, immune cell subsets, and dynamic changes in serological indicators in patients with myasthenia gravis (MG) before and after efgartigimod (EFG) treatment. Methods
We analyzed the baseline data, laboratory parameters, and lymphocyte subset proportions in MG ...Tiancheng Luo, Deyou Peng, Zhouao Zhang, Mingjin Yang, Xinyan Guo, Tianyu Ma, Xiaoyu Huang, Mingming Xu, Linlin Fu, Yong Zhang +9 morewiley +1 more source